You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly Diagnosed Glioblastoma Multiforme, vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

Recruiting
  • Glioblastoma Multiforme of Brain
  • Autologous dendritic cells pulsed with multiple neoantigen peptides.
  • Temozolomide adjuvant chemotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 13, 2022

Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • pp65-shLAMP DC with GM-CSF
  • +4 more
  • Gainesville, Florida
  • +2 more
Jan 6, 2022

Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

Completed
Has Results
  • Glioblastoma
  • +3 more
  • Unpulsed DCs
  • +6 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 3, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Glioblastoma Trial in Milano (Dendritic Cells Vaccine)

Recruiting
  • Glioblastoma
  • Dendritic Cells Vaccine
  • Milano, Italy
    UOC Neuro-oncologia Molecolare
Mar 13, 2021

Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)

Completed
  • Malignant Neoplasms Brain
  • Durham, North Carolina
    Duke University Medical Center
Mar 8, 2021

Glioblastoma Multiforme Trial (WP1066)

Not yet recruiting
  • Glioblastoma Multiforme
  • (no location specified)
May 18, 2023

Glioblastoma Multiforme of Brain Trial in Gatineau (avelumab)

Completed
  • Glioblastoma Multiforme of Brain
  • avelumab
  • Gatineau, Quebec, Canada
    Clinique Neuro-Outaouais
Jul 19, 2022

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Glioblastoma Multiforme (GBM) Trial in Taoyuan (ADI-PEG20, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou Branch
Sep 29, 2022

Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,

Terminated
Has Results
  • Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
  • Chemotherapy with Temodar.
  • Radiation therapy
  • Baltimore, Maryland
    Ummc Msgcc
Dec 1, 2022

Glioblastoma Trial in Boston (ITI-1001)

Not yet recruiting
  • Glioblastoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 13, 2023

Glioblastoma Multiforme Trial in Nice (Pazopanib)

Active, not recruiting
  • Glioblastoma Multiforme
  • Nice, Cedex 2, France
    Centre Antoine Lacassagne
Mar 3, 2022

Glioblastoma Multiforme of Brain Trial in Edegem (Dendritic cell vaccine plus temozolomide chemo)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Dendritic cell vaccine plus temozolomide chemotherapy
  • Edegem, Antwerp, Belgium
    Antwerp University Hospital
Jan 15, 2021

Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Multipeptide plus XS15
  • Tübingen, BW, Germany
    University Hospital Tübingen
May 9, 2022

Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

Recruiting
  • Anaplastic Oligoastrocytoma
  • Glioblastoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2022

Glioblastoma Multiforme Trial (Atezolizumab + FSRT radiation)

Not yet recruiting
  • Glioblastoma Multiforme
  • Atezolizumab + FSRT radiation
  • (no location specified)
Jun 14, 2022

Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

Not yet recruiting
  • Unmethylated Glioblastoma
  • Personalized Neoantigen DNA vaccine
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 14, 2023

Brain and CNS Tumors Trial in United States (biological, drug, procedure)

Completed
Has Results
  • Brain and Central Nervous System Tumors
  • HSPPC-96
  • +2 more
  • San Francisco, California
  • +8 more
Mar 23, 2021

Glioblastoma Multiforme Trial in United States (Keto Diet, Usual Diet)

Not yet recruiting
  • Glioblastoma Multiforme
  • Keto Diet
  • Usual Diet
  • Los Angeles, California
  • +4 more
Jan 31, 2023

Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 22, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Neoplastic Disease, Glioblastoma, Glioblastoma Multiforme Trial (131I-IPA)

Not yet recruiting
  • Neoplastic Disease
  • +2 more
  • (no location specified)
Jul 6, 2022